NCT00092547View on ClinicalTrials.gov

A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,781

Participants

Timeline

Start Date

October 8, 2003

Primary Completion Date

November 3, 2005

Study Completion Date

June 1, 2015

Conditions
HumanPapillomavirus Infections
Interventions
BIOLOGICAL

V501

0.5 mL intramuscular injection of V501

BIOLOGICAL

Comparator: Placebo

0.5 mL intramuscular injection of placebo

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092547 - A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018) | Biotech Hunter | Biotech Hunter